| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $437,275,125 ) (Continued on the next page) |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01HG012304 | High-throughput analysis of the effects of gene promoters and chromosomal environments on single-cell gene expression | 000 | 3 | NIH | 1/10/2024 | $378,235 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01CA260112 | Impact of cancer predisposition on oncogenic process, microenvironment, and treatment | 000 | 3 | NIH | 12/25/2023 | $427,827 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01CA260066 | Molecular Biomarkers of Long-Term Response to Androgen Deprivation Therapy and Radiation in Prostate Cancer | 001 | 3 | NIH | 4/17/2024 | $32,026 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01CA260066 | Molecular Biomarkers of Long-Term Response to Androgen Deprivation Therapy and Radiation in Prostate Cancer | 000 | 3 | NIH | 12/21/2023 | $576,462 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01AI162591 | Autoimmune Diabetes: Macrophage Responses | 001 | 3 | NIH | 5/23/2024 | $46,555 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01HL159171 | Mechanistic Studies of the Novel Human Coronary Artery Disease Gene SVEP1 | 001 | 3 | NIH | 6/20/2024 | $43,082 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | F30AI186244 | Enhancer Hijacking of the IgH Locus as a Novel Genetic Mechanism of Inborn Errors of Immunity | 000 | 1 | NIH | 7/23/2024 | $35,482 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01HL174789 | Mechanisms and relevance of miRNA decay during hematopoietic development | 000 | 1 | NIH | 7/23/2024 | $657,368 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | AY2AX000015 | The NITRO Consortium; Joint Regeneration in Osteoarthritis | 000 | 1 | NIH | 3/26/2024 | $11,308,108 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110-4899 | SAINT LOUIS CITY | USA | M0142009 | Behavioral Health Workforce Education and Training Program | 00 | 4 | HRSA | 6/18/2024 | $122,718 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | F31NS139506 | Understanding the Role of Histone Ubiquitination in Plasticity and Neurodevelopmental Disease | 000 | 1 | NIH | 7/22/2024 | $34,623 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R37CA267905 | Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy | 001 | 3 | NIH | 4/17/2024 | $20,868 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R37CA267905 | Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy | 000 | 3 | NIH | 12/22/2023 | $375,638 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01DE032371 | Dissecting hybrid epithelial-mesenchymal states in head and neck cancer | 001 | 2 | NIH | 6/13/2024 | $31,334 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01DE032371 | Dissecting hybrid epithelial-mesenchymal states in head and neck cancer | 000 | 2 | NIH | 11/14/2023 | $352,500 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01HD108639 | Dissecting the function of Nemp1, a nuclear envelope protein critical for mammalian fertility | 001 | 2 | NIH | 5/2/2024 | $50,873 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01HD108639 | Dissecting the function of Nemp1, a nuclear envelope protein critical for mammalian fertility | 000 | 2 | NIH | 11/16/2023 | $508,724 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R37CA259359 | Dysregulated genome architecture in acute myeloid leukemia | 001 | 3 | NIH | 4/16/2024 | $17,786 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R37CA259359 | Dysregulated genome architecture in acute myeloid leukemia | 000 | 3 | NIH | 1/22/2024 | $320,136 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01HD110556 | Multi-organism platform for functional assessment of human birth defect associated genomic variants | 001 | 2 | NIH | 5/6/2024 | $57,267 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01HD110556 | Multi-organism platform for functional assessment of human birth defect associated genomic variants | 000 | 2 | NIH | 11/29/2023 | $572,683 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | K23HL171940 | Implementation of SMART therapy for asthma patients in low-resource community health centers | 002 | 1 | NIH | 6/28/2024 | $21,511 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | K23HL171940 | Implementation of SMART therapy for asthma patients in low-resource community health centers | 003 | 1 | NIH | 7/15/2024 | $75,600 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | K23HL171940 | Implementation of SMART therapy for asthma patients in low-resource community health centers | 001 | 1 | NIH | 2/9/2024 | $189,281 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | K23HL171940 | Implementation of SMART therapy for asthma patients in low-resource community health centers | 001 | 1 | NIH | 2/9/2024 | -$189,281 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | K23HL171940 | Implementation of SMART therapy for asthma patients in low-resource community health centers | 000 | 1 | NIH | 1/23/2024 | $189,281 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01DK128188 | Pathophysiology of Chronic Pancreatitis Associated with Misfolded PNLIP Risk Variants | 001 | 3 | NIH | 5/15/2024 | $25,922 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01DK128188 | Pathophysiology of Chronic Pancreatitis Associated with Misfolded PNLIP Risk Variants | 000 | 3 | NIH | 12/12/2023 | $388,828 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01AG085374 | Role of T cells in tau-mediated neurodegeneration | 000 | 1 | NIH | 1/23/2024 | $750,628 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01HL166448 | Investigating altered smooth muscle cell mechanotransduction as a cause of supravalvular aortic stenosis | 000 | 2 | NIH | 11/6/2023 | $388,750 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R13AR084891 | ORS/ISFR 18th Biennial Meeting (Orthopaedic Research Society/International Section for Fracture Repair | 000 | 1 | NIH | 7/18/2024 | $7,000 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R13AR084891 | ORS/ISFR 18th Biennial Meeting (Orthopaedic Research Society/International Section for Fracture Repair | 000 | 1 | NIH | 7/18/2024 | $5,000 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R13AR084891 | ORS/ISFR 18th Biennial Meeting (Orthopaedic Research Society/International Section for Fracture Repair | 000 | 1 | NIH | 7/18/2024 | $3,000 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01AI168918 | Mechanisms of Nanomaterials-based Combination Adjuvants | 001 | 2 | NIH | 5/14/2024 | $49,870 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01AI168918 | Mechanisms of Nanomaterials-based Combination Adjuvants | 000 | 2 | NIH | 11/29/2023 | $448,837 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R21OD033668 | Increasing the efficiency and range of prime editing for disease modeling in zebrafish | 001 | 2 | NIH | 5/14/2024 | $38,875 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R21OD033668 | Increasing the efficiency and range of prime editing for disease modeling in zebrafish | 000 | 2 | NIH | 1/18/2024 | $155,500 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01AI173203 | Unraveling Human T Follicular Helper Cell Development | 001 | 2 | NIH | 5/14/2024 | $59,782 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R01AI173203 | Unraveling Human T Follicular Helper Cell Development | 000 | 2 | NIH | 12/1/2023 | $538,036 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R00AG070105 | Investigating whole-body innate immune activation in Alzheimer's disease using PET imaging and immune profiling | 001 | 4 | NIH | 6/14/2024 | $24,900 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R00AG070105 | Investigating whole-body innate immune activation in Alzheimer's disease using PET imaging and immune profiling | 000 | 4 | NIH | 1/19/2024 | $224,100 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R21AI185223 | Mechanism of neutrophil dysfunction by Plasmodium falciparum secreted histidine-rich protein II | 000 | 1 | NIH | 7/22/2024 | $209,925 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R35HL171080 | Mitofusin 2 as a Nodal Regulator of Mitochondrial Function in Cardiomyopathy | 001 | 1 | NIH | 1/31/2024 | -$1,088,500 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R35HL171080 | Mitofusin 2 as a Nodal Regulator of Mitochondrial Function in Cardiomyopathy | 001 | 1 | NIH | 1/31/2024 | $1,088,500 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R35HL171080 | Mitofusin 2 as a Nodal Regulator of Mitochondrial Function in Cardiomyopathy | 000 | 1 | NIH | 1/1/2024 | $1,088,500 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R00CA256039 | Dissecting reciprocal interactions between cancer cells and endothelial cells in SCLC liver metastasis. | 000 | 3 | NIH | 1/17/2024 | $224,100 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | R37CA285572 | Decoding 41BB-specific dysfunction programs in cellular immunotherapies for cancer | 000 | 1 | NIH | 12/19/2023 | $355,706 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | F30HL172583 | Exploring the immunomodulatory effects of anti-FAP CAR T cells in cardiac fibrosis | 001 | 1 | NIH | 1/24/2024 | $0 |
| 2024 | 2024 | WASHINGTON UNIVERSITY, THE | ONE BROOKINGS DR | SAINT LOUIS | MO | 63110 | SAINT LOUIS CITY | USA | K99AT012651 | Expanding the therapeutic capacity of Saccharomyces cerevisiae var. boulardii for the treatment of gastrointestinal infections | 000 | 1 | NIH | 1/25/2024 | $120,866 |
|